Abstract
Rapid development of modern areas of biomedical science contributes to the increase of the implementation rate, of innovative products and services in medicine, in particular, clinical oncology. The purpose of the article is the comparative analysis of the experience of R&D results commercialization in biomedical sector of the developed countries and Ukraine. The study uses methods of structural and logical analysis and comparative content analysis. Commercialization fits the inventor interests in using intellectual property, provides its implementation, and reveals commercial advantages to continue scientific and innovative activity. Society is interested in successful commercialization and technology transfer in biomedical field that increase competitiveness level of health system. Such activity stimulates scientists to develop innovative products. In foreign countries, legal and organizational mechanisms have been created that stimulate of investment activities for conducting research in the biomedical science at universities and scientific institutions. The development of links in the field of commercialization of R&D results has become a priority of the innovation policy of many countries, and public-private partnerships are an effective tool for its implementation, as evidenced by the rising of national budgets, legislative initiatives and the development of new programs. The analysis of the foreign experience of technology transfer of medical and biological R&D results allows to highlight several points: the financial support of research institutes and universities is considered as an important function of the state; public financing of projects in the field of medicine and biology is carried out within a quite long period of time (often not less than10 years), and the purchase of equipment is not a central item of expenditures; assessment of the productivity of researchers is complemented by evaluating the performance of the departments responsible for research management and funding; quantitative indicators of research unit results are supplemented by expert assessments of the quality of research, effectiveness and safety of medical developments based on new knowledge and achievements of scientific and technological progress. Conclusion. In Ukraine, despite certain difficulties in recent years, the high scientific potential in the field of biomedical sciences provides an increase of the number of high-tech innovative scientific and technological developments. Taking into account the low innovative activity of scientific institutions and universities, commercialization requires a systematic state approach, the development of strategies, specific mechanisms, methods and forms
Highlights
Current rapid development of biomedical science contributes to development of innovative products and services in domestic scientific research institutes and universities
In Ukraine, despite certain difficulties in recent years, the high scientific potential in the field of biomedical sciences provides an increase of the number of high-tech innovative scientific and technological developments
The study was performed in accordance with the R&D of the Department of Research Management and Innovation of the RE Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of the National Academy of Sciences of Ukraine “Development of strategies for technology transfer in oncology practice, taking into account the specifics of Ukraine”, state registration No 0119U103932
Summary
The comparative analysis of domestic and foreign experience of biomedical R&D results commercialization shows that there is a high level of development in economically developed countries, which is provided, first of all, by state support for forming close ties between business and research institutes and universities to create new techcenters of technology that make extensive use of various mechanisms and forms of technology transfer. In Ukraine, despite the considerable difficulties and barriers between high scientific potential, on the one hand, and low innovation activity of research organizations, on the other, there is an increase of high-tech innovative scientific and technological developments in the field of biomedical sciences. Their сcommercialization requires systematic state approach to the development of strategies, specific mechanisms, methods and forms
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
